Policy uncertainty is muddling retirement planning — and advisers are just as confused
Market optimism may be masking deep retirement risks.
Similar Posts
Affinius Capital Provides $188M Refi for N.J. Mixed-Use Apartment Complex – Commercial Observer
A joint venture among PCCP, Claremont Development, and Stanbery Development Group has secured $188 million to refinance the District 15Fifteen, a 498-unit multifamily property in Parsippany, N.J., Commercial Observer can first report. Affinius Capital provided the debt, which will finance the lease-up and stabilization of the property, as it opened only last month. Cushman &…
Rupee rises 28 paise to 96.25 against US dollar during early trade | Finance News
The rupee gained 28 paise to 96.25 against the US dollar in early trade on Monday, taking cues from a sharp fall in crude oil prices and positive global sentiment after the US and Iran signalled an easing of tensions in West Asia. The American currency index also retreated from an elevated level,…
Tritax Big Box secures planning consent for Slough data centre scheme
Your trusted source for commercial real estate intelligence, insights, and market analysis. Register for free to access two complimentary articles per month, or Subscribe to unlock unlimited CRE intelligence. Already have an account? Log in
Super Micro surges on new order disclosure after SpaceX announcement
Super Micro Computer CEO Charles Liang speaks at the Raise summit in Paris on July 8, 2025. Nathan Laine | Bloomberg | Getty Images Shares of Super Micro Computer jumped 15% after the server maker said Tuesday it now sees higher margins than previously projected for the June quarter, with a surge in new orders….
Data Doesn’t Support Millionaires Fleeing Mamdani Narrative
Hating on New York City for a living A friend shared this Twitter/X post, and I first thought, well, this is on-brand politically. But with a little research, it is clear that this headline is also wildly misleading. After I read the piece, the first thing I did was ask Grok, the native AI on…
Dr Reddy’s shares crash 9% in 2 days; brokerages slash target prices after semaglutide supply disruption. What lies ahead?
The shares of Dr Reddy’s Laboratories tumbled another 4% on Friday, extending their decline to more than 9% over two days after the company said commercial supplies of its semaglutide product would be delayed due to a quality-related issue involving the active pharmaceutical ingredient (API) used in certain batches. The pharma company’s shares fell to…
